← Back to headlines




GLP-1 Receptor Agonists Show Promise for Dermatological Conditions
New research suggests that GLP-1 receptor agonists, drugs typically used for type 2 diabetes and obesity, may possess anti-inflammatory properties beneficial for patients with dermatological diseases. This finding comes from a summary of current knowledge on their application in dermatology.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories

Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
1h ago

New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
1h ago

Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
5h ago

Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
11h ago